 Cytotoxic T-lymphocyte response human allogeneic bone marrow transplantation pattern recovery correlation cytomegalovirus infection disease high rate severe cytomegalovirus CMV disease bone marrow transplantation BMT profound immunodeficiency posttransplant cytotoxic lymphocytes CTL resistance viral infections restoration CMV-specific CTL response patients bone marrow HLA-matched CMV-seropositive donors Blood specimens patients months BMT donors single occasion Peripheral blood mononuclear cells CMV-infected donor-derived fibroblasts weeks cytotoxicity CMV-infected uninfected autologous HLA-mismatched fibroblasts Cytolytic activity donors specificity autologous CMV-infected targets demonstrable median CMV-specific lysis effector target ratio Specific lysis class I-restricted cells inhibition anti-class antibody selective depletion effector cells contrast CMV-specific CTL patients BMT median lysis months post-BMT None patients CMV pneumonia patients undetectable CMV-specific CTL response BMT CMV pneumonia results restoration CMV-specific CTL responses extended time period BMT patients patients increased risk severe CMV disease Approaches CMV immunity BMT patients adoptive transfer CMV-specific CTL clones bone marrow donor